Portfolio
As of March 31, 2020
NBPE Summary
| NBPE $ in millions, except per share | 3/31/2020 | 2/29/2020 (Restated) |
| Equity Investments | $955.9 | $959.6 |
| Income Investments | 109.6 | 105.8 |
| Total Direct Investments | $1,065.4 | $1,065.4 |
| Legacy Private Equity Funds | 31.8 | 37.3 |
| Total Private Equity Fair Value | $1,097.3 | $1,102.7 |
| Cash | 149.6 | 9.2 |
| Credit Facility Borrowings | (250.0) | (90.0) |
| ZDPs | (138.1) | (141.8) |
| Dividend Payable | - | - |
| Other Assets / Liabilities (Net) | (14.9) | (13.4) |
| Net Asset Value | $843.8 | $866.6 |
| Net Asset Value Per Share | $18.04 | $18.52 |
| Capital Position | 3/31/2020 | 2/29/2020 |
| Investment Level | 130% | 127% |
| Cash + Available Credit Facility | 149.6 | 169.2 |
| Adjusted Unfunded Commitments | 142.0 | 145.9 |
| Adjusted Commitments Coverage Ratio | 105% | 116% |
| Sterling NAV & Trading Information (£) | 3/31/2020 | 2/29/2020 |
| NAV Per Share | £14.55 | £14.50 |
| Closing Share Price | £6.84 | £11.00 |
| Discount to NAV | (53.0%) | (24.5%) |
Asset Overview
TOP 10 POSITIONS BY FAIR VALUE
| Investment | Inv. Date | Industry | Fair Value ($m) | % of Value |
|---|---|---|---|---|
| MHS | 2017 | Industrials | 37.4 | 3.4 |
|
|
||||
| Engineering | 2016 | TMT | 32.6 | 3.0 |
|
|
||||
| ProAmpac | 2017 | Industrials | 32.5 | 3.0 |
|
|
||||
| USI | 2017 | Financial Services | 32.0 | 2.9 |
|
|
||||
| Marquee Brands | 2014 | Consumer | 31.0 | 2.8 |
|
|
||||
| Business Services Company (Undisclosed) | 2017 | Business Services | 30.9 | 2.8 |
|
|
||||
| LGC | 2016 | Healthcare | 27.4 | 2.5 |
|
|
||||
| Cotiviti | 2018 | Healthcare | 26.5 | 2.4 |
|
|
||||
| Action | 2020 | Consumer | 24.9 | 2.3 |
|
|
||||
| Agiliti | 2019 | Healthcare | 23.2 | 2.1 |
|
|
||||
| Total | 298.4 | 27.2 | ||
INVESTOR RELATIONS
NBPE’s Class A ordinary shares are admitted to trading on the Premium Segment of the Main Market of the London Stock Exchange
LEARN MORE